SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-072463
Filing Date
2018-12-12
Accepted
2018-12-12 08:39:47
Documents
3
Period of Report
2018-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-41401_18k.htm 8-K 23068
2 EX-99.1 a18-41401_1ex99d1.htm EX-99.1 8515
3 GRAPHIC g414011mmi001.jpg GRAPHIC 5500
  Complete submission text file 0001104659-18-072463.txt   40738
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 181230081
SIC: 2836 Biological Products, (No Diagnostic Substances)